<DOC>
	<DOC>NCT02676596</DOC>
	<brief_summary>The purpose of this study is to investigate the safety tolerability, and PK profile of K-312 and its metabolites in healthy Japanese and non-Japanese adults.</brief_summary>
	<brief_title>Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of K-312 in Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Hyperlipidemias</mesh_term>
	<criteria>Subject provides written informed consent before any studyspecific evaluation is performed. Subject is a healthy adult male or a female of nonchildbearing potential between the ages of 18 and 45 years, inclusive. Subject has a body mass index of 18.5 to 30 kg/m2, inclusive. Subject has hematology, coagulation, serum chemistry, and urinalysis test results within the reference ranges or showing no clinically relevant deviations, as judged by the Investigator. Subject has the presence of an active or recurring clinically significant cardiovascular, pulmonary, renal, endocrine, hepatic, neurologic, psychiatric, immunologic, hematologic, gastrointestinal, or metabolic disease requiring medical treatment. Subject has any surgical or medical condition that might significantly alter the absorption, distribution, metabolism, or excretion of K312. Cholecystectomy is permitted if there are no postcholecystectomy gastrointestinal symptoms. Subject has clinically relevant abnormalities in clinical laboratory parameters.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>